← Eichor
Study identifier: NCT07338045 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effects of Eight-Week Baduanjin Exercise on Chronic Low Back Pain and Disability Among Office Workers.

Condition: Low Back Pain · Baduanjin  ·  Sponsor: Universiti Sains Malaysia

PhaseNA
Planned participants30
Who can joinAll sexes, 20 Years to 55 Years
Healthy volunteersNo

About this study

Office workers often suffer from chronic low back pain due to long hours of sitting and poor posture. This study will test whether Baduanjin-a gentle, traditional Chinese exercise-can help reduce pain and improve physical function in office staff with long-standing back pain. Thirty participants will be randomly assigned to either practice Baduanjin for eight weeks or receive no special intervention. Researchers will measure changes in pain levels, movement ability, balance, posture, and daily functioning before and after the program. Baduanjin is a safe, low-cost, and easy-to-learn exercise that could be widely used in community health settings as a non-drug therapy for back pain.

This description comes directly from the study's public registry record.

Talk to the study team

YANAN QI, MSc (Master of Science)  ·  +86 18612567294  ·  QIYANAN@student.usm.my

Always discuss trial participation with your own doctor first.

Locations (1)

Xi'an Jiaotong University City CollegeXi'an, Shaanxi, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07338045